Glenmark will be responsible for further developing, registering, and commercializing Envafolimab in India, Asia Pacific, Middle East and Africa, Russia, CIS, and Latin America
The new campus has been designed as an employee-centred experience and ecosystem zone
Inducts advanced AI-Powered 24x7 remote patient monitoring system
Atlas AI combines NVIDIA BioNeMo cloud APIs for intelligent chemical and protein design
Arco Lab now holds a 50% stake in Neviton
This agreement includes upfront and milestone payments with a combined potential value of over $500m and sales royalties.
The company received gross proceeds of approximately US$1.7 million and net proceeds,
Sirius JV will be owned 51% by Sirius and 49% by Adani
Funding round led by Sarissa Capital, includes Sun Pharma, Polaris Partners
Transaction delivers KarXT, a first-in-class M1/ M4 muscarinic receptor agonist with differentiated efficacy and safety
Subscribe To Our Newsletter & Stay Updated
